Vineet Agarwal serves as the Chief Financial Officer at KORRO BIO INC, a biotechnology company focused on developing transformative genetic medicines. With a robust background in finance and strategic planning, Vineet has been instrumental in guiding KORRO BIO through various stages of growth and development. Prior to joining KORRO BIO, Vineet held significant positions at several high-profile biotech and pharmaceutical companies, where he honed his skills in financial management and corporate strategy. In his role as CFO at KORRO BIO, Vineet is responsible for overseeing the company's financial operations, including budgeting, forecasting, and financial reporting. His strategic vision has been crucial in securing funding and managing the company's resources effectively, ensuring that KORRO BIO remains on a solid financial footing as it advances its innovative genetic medicine programs. Vineet's leadership has been pivotal in navigating the complex financial landscape of the biotech industry, allowing KORRO BIO to focus on its mission of bringing life-changing therapies to patients. Vineet's achievements extend beyond his current role at KORRO BIO. He has a proven track record of driving financial performance and growth in the biotech sector. His expertise in financial planning and analysis, coupled with his deep understanding of the industry, has enabled him to make significant contributions to the companies he has worked with. Vineet holds a degree in finance from a prestigious university and is known for his ability to translate complex financial data into actionable insights, making him a valuable asset to KORRO BIO and the broader biotech community.